The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
Public ClinicalTrials.gov record NCT01106690. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Pioglitazone Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receving treatment with metformin and pioglitazone and have inadequate glycemic (blood sugar) control.
Study identification
- NCT ID
- NCT01106690
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 344 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Canagliflozin Drug
- Sitagliptin Drug
- Metformin Drug
- Pioglitazone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- Nov 2011 (Actual)
- Completion
- Jul 2012 (Actual)
- Last update posted
- Jul 15, 2013
2010 – 2012
United States locations
- U.S. sites
- 41
- U.S. states
- 19
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anniston | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Burlingame | California | — | — |
| Not listed | Encinitas | California | — | — |
| Not listed | Fullerton | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | Santa Ana | California | — | — |
| Not listed | Wes Hills | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Bartow | Florida | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Des Moines | Iowa | — | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Chaska | Minnesota | — | — |
| Not listed | Picayune | Mississippi | — | — |
| Not listed | Billings | Montana | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Hickory | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Dublin | Ohio | — | — |
| Not listed | Perrysburg | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Yukon | Oklahoma | — | — |
| Not listed | Bensalem | Pennsylvania | — | — |
| Not listed | Bristol | Tennessee | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Grand Prairie | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | New Braunfels | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Falls Church | Virginia | — | — |
| Not listed | Virginia Beach | Virginia | — | — |
| Not listed | Federal Way | Washington | — | — |
| Not listed | Selah | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01106690, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2013 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01106690 live on ClinicalTrials.gov.